Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

ConditionRetinal Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age20-50

SponsorEL Romany Ophthalmics Factory

About this trial

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

- Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;

Disqualifiers

Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Trial population

primary care clinic

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

20 Participants

are grouped into 1 trial group

Group A: eye surgery ,Vitreoretinal Surgery and Related Ocular Inflammation

Trial outcomes

Primary outcomes

flat the detached retina and displace the underneath fluids anteriorly

the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina

Time frame

Base line

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

EL Romany Ophthalmics Factory

Lead sponsor

Source ClinicalTrials.gov

Apply now